arrow_back Back Filing freshness 20-F FY 2025 SEC EDGAR

download Export Data

Burning Rock Biotech Ltd

BNR

$9.00 ▼ -0.05 (-0.55%) at close

7 Visible periods

21 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

Burning Rock Biotech Ltd faces fundamental challenges with weakness in Profit Margin (%) and Operating Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap —

Dividend Yield —

Revenue Growth 9.2% ↗

Op. Margin -10.2% ↗

ROIC -8.1% ↗

FCF / Share —

Trailing P/E —

Price / Book —

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 7, 2026.

7-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$77.16M

↑ +9.2% —

Net Income Profit after all expenses

$-7.92M

↑ +83.3% —

Operating Margin Operating profit as % of sales

-10.2%

↑ +85.3% 15th

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Operating Margin (%)Operating Margin (%) is in the bottom quartile
Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability ↑

Returns ↑

Financial Health ↓

Cash Quality ↓

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 4 metrics

Metric	FY 2025 Dec 31, 2025 20-F ↗	FY 2024 Dec 31, 2024 20-F ↗	FY 2023 Dec 31, 2023 20-F ↗	FY 2022 Dec 31, 2022 20-F ↗	FY 2021 Dec 31, 2021 20-F ↗	FY 2020 Dec 31, 2020 20-F ↗	FY 2019 Dec 31, 2019 20-F ↗
Revenue Growth YoY (%)	9.2% Fair ↑ Fair Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+15%)	-6.6% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-183%)	-7.3% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-191%)	2.5% Caution Caution Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-69%)	21.0% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+162%)	—	—
Net Income Growth YoY (%)	83.3% Excellent ↑ Excellent Improving Year-over-year change in net income	48.4% Excellent ↑ Excellent Improving Year-over-year change in net income	34.6% Excellent ↑ Excellent Improving Year-over-year change in net income	-12.6% Weak Weak Year-over-year change in net income	-100.3% Weak Weak Year-over-year change in net income	—	—
Revenue CAGR 3Y (%)	-1.9% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-3.9% Weak Weak Compound annual revenue growth over 3 years	4.7% Caution Caution Compound annual revenue growth over 3 years	—	—	—	—
Revenue CAGR 5Y (%)	3.2% Caution Caution Compound annual revenue growth over 5 years	—	—	—	—	—	—

💰 Are margins durable? 4 metrics

Metric	FY 2025 Dec 31, 2025 20-F ↗	FY 2024 Dec 31, 2024 20-F ↗	FY 2023 Dec 31, 2023 20-F ↗	FY 2022 Dec 31, 2022 20-F ↗	FY 2021 Dec 31, 2021 20-F ↗	FY 2020 Dec 31, 2020 20-F ↗	FY 2019 Dec 31, 2019 20-F ↗
Operating Margin (%) (%)	-10.2% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-168%)	-69.3% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-562%)	-124.5% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-930%)	-174.1% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1260%)	-156.9% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1146%)	-95.9% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-740%)	—
Profit Margin (%) (%)	-10.3% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-185%)	-67.2% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-660%)	-121.6% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1114%)	-172.4% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1537%)	-156.9% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1407%)	-94.7% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-889%)	—
FCF Margin (%) (%)	-6.2% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-18.9% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-49.1% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-92.1% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-134.3% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-31.1% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—
FCF / Net Income (x)	0.61x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.28x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.40x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.53x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.86x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.33x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 20-F ↗	FY 2024 Dec 31, 2024 20-F ↗	FY 2023 Dec 31, 2023 20-F ↗	FY 2022 Dec 31, 2022 20-F ↗	FY 2021 Dec 31, 2021 20-F ↗	FY 2020 Dec 31, 2020 20-F ↗	FY 2019 Dec 31, 2019 20-F ↗
Return on Invested Capital (%)	-8.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-48.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-68.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-66.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-34.1% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-13.5% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-6.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-40.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-64.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-61.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-35.0% Weak Weak Operating profit relative to total assets Optimal: > 10%	-15.5% Weak Weak Operating profit relative to total assets Optimal: > 10%	—
Return on Common Equity (%) (%)	-10.3% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-169%)	-59.7% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-498%)	-85.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-667%)	-83.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-659%)	-43.2% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-388%)	-16.8% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-212%)	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2025 Dec 31, 2025 20-F ↗	FY 2024 Dec 31, 2024 20-F ↗	FY 2023 Dec 31, 2023 20-F ↗	FY 2022 Dec 31, 2022 20-F ↗	FY 2021 Dec 31, 2021 20-F ↗	FY 2020 Dec 31, 2020 20-F ↗	FY 2019 Dec 31, 2019 20-F ↗
Debt to Equity (x)	—	—	—	0.00x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-100%)	0.00x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-100%)	0.00x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-99%)	—
Interest Coverage (x)	-1961.00x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	-1119.25x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-519.00x Weak Weak Operating income divided by interest expense Optimal: > 5x	-619.66x Weak Weak Operating income divided by interest expense Optimal: > 5x	—
Net Debt (USD)	$-68.41M	$-71.22M	$-86.63M	$-131.28M	$-224.23M	$-289.34M	—
Debt / EBITDA (x)	—	—	—	0.00x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.00x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.02x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	FY 2025 Dec 31, 2025 20-F ↗	FY 2024 Dec 31, 2024 20-F ↗	FY 2023 Dec 31, 2023 20-F ↗	FY 2022 Dec 31, 2022 20-F ↗	FY 2021 Dec 31, 2021 20-F ↗	FY 2020 Dec 31, 2020 20-F ↗	FY 2019 Dec 31, 2019 20-F ↗
Working Capital (USD)	$70.30M	$69.91M	$87.43M	$122.85M	$227.34M	$349.75M	—
Total Equity (USD)	$76.54M	$79.57M	$108.23M	$167.94M	$289.57M	$371.04M	—

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 20-F ↗	FY 2024 Dec 31, 2024 20-F ↗	FY 2023 Dec 31, 2023 20-F ↗	FY 2022 Dec 31, 2022 20-F ↗	FY 2021 Dec 31, 2021 20-F ↗	FY 2020 Dec 31, 2020 20-F ↗	FY 2019 Dec 31, 2019 20-F ↗
Sales/Revenue/Turnover (USD)	$77.16M	$70.67M	$75.70M	$81.66M	$79.69M	$65.89M	—
Depreciation Expense (USD)	$3.11M	$7.15M	$18.79M	$17.99M	$7.50M	$5.11M	—
Net Income, GAAP (USD)	$-7.92M	$-47.49M	$-92.07M	$-140.81M	$-125.02M	$-62.41M	—
Operating Cash Flow (USD)	$-4.07M	$-12.64M	$-36.03M	$-66.23M	$-74.99M	$-11.27M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 7 years · 7 quarters

Burning Rock Biotech Ltd

Analytical Summary

7-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare BNR with peers